PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights [Yahoo! Finance]
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences